Ana Pejovic-Milic

Dr. Pejović-Milić is among an elite group of researchers who are conducting studies in the new and growing field of medical and health physics, in the North American center of BioMedical research in Toronto, Canada. These disciplines rest on the application and use of physics in medicine, and Dr. Pejović-Milić work has practical implications for understanding diseases such as bone degeneration and eye health, as well as nanoparticle enhanced cancer therapies.

Dr. Pejović-Milić’ s research group is currently developing in vivo X-ray fluorescence (XRF) based diagnostic techniques that will be used to assess the health consequences of strontium, lanthanum, tungsten and gadolinium, to mention some, accumulated in human bone. Her research team is actively developing a Total Reflection X-ray fluorescence (TXRF) based approach to quantification of nanoparticles, such as gold and silver nano-particles, to aid future cancer therapies. Novel work on using TXRF to quantify trace elements in human tissues, such as in the nasolacrimal duct tissue, to evaluate eye health are also part of her research interests.

Dr. Pejović-Milić is a Chair of the Department of Physics at Ryerson University (Toronto, Canada) since 2010. Along with her administrative duties, she is a prolific researcher, with over 60 peer review publications and 180 conference presentations. Her research team includes postdoctoral fellows, graduate and undergraduate students, all working on the use of techniques based in atomic and nuclear physics for non-destructive (in vivo) and destructive (ex vivo) elemental analysis of human tissues.